A brand name identifies a marketed drug product; a generic name identifies its active ingredient. A generic medication approved by the Food and Drug Administration (FDA) matches its reference brand in ingredient, strength, dosage form and how it is taken, with the same expected benefit and risks. Differences can include appearance, some inactive ingredients and price.
If you’re preparing for the Pharmacy Technician Certification Exam (PTCE), learn to connect names to ingredients and then compare the full product descriptions. Recognizing a brand/generic pair is useful, but it doesn’t answer every question about whether two products can replace each other. FDA’s overview of generic medications explains the approval standards behind that distinction.
Table of Contents
- What brand and generic names tell you
- How brand and generic products compare
- Bioequivalence and therapeutic equivalence
- Why generic medications usually cost less
- Three technician practice scenarios
- Related terms you’ll encounter
- Four study steps for brand and generic medications
What brand and generic names tell you
The Pharmacy Technician Certification Board (PTCB) includes medication names and classifications, therapeutic duplications, and product strengths, forms and administration methods in its content outline effective January 2026. Those topics fit together: first identify the drug, then pay attention to the details that describe the product.
The active ingredient is the substance that produces a medicine’s treatment effect. A brand label also displays its ingredient name. For example, Lipitor is a brand product, and its label identifies atorvastatin as the drug ingredient. Seeing the word “atorvastatin” on that label does not turn Lipitor into a generic product.
Use these four examples to practice separating the two names:
| Brand product | Generic name to recognize | Detail from the product label |
|---|---|---|
| Lipitor | atorvastatin | The label identifies atorvastatin calcium; the medicine is a statin. |
| Synthroid | levothyroxine | The label identifies levothyroxine sodium tablets. |
| Tylenol Regular Strength tablets | acetaminophen | The named product contains 325 mg per tablet. |
| Advil coated tablets | ibuprofen | The named product contains 200 mg per tablet. |
In practice, read beyond the large brand name. In the Lipitor and Synthroid examples, calcium and sodium identify the salt form of the ingredient. Keep the complete product description in view rather than using a memorized name pair as a substitute for reading the label.
The strengths above describe those specific products, not a dose to recommend. Brand families can include products with different ingredients or formulations. For an over-the-counter product, the active-ingredient section of the Drug Facts panel identifies what is actually in it. FDA’s guide to the Drug Facts label shows how to read that information.
How brand and generic products compare
A dosage form is the physical form of the medicine, such as a tablet, capsule or liquid. The route of administration is how it enters the body, such as by mouth or injection. These details belong beside the name and strength when you compare products.
| Characteristic | Brand reference product | Its FDA-approved generic |
|---|---|---|
| Active ingredient | The drug ingredient in the reference product | The same active ingredient |
| Strength | The amount of active ingredient in that product | The same strength |
| Dosage form | A particular tablet, capsule, liquid or other form | The same dosage form |
| How it is administered | The labeled method, such as by mouth or injection | The same method |
| Treatment effect and quality | Safety and effectiveness established for approval | The same expected benefit and risks; must meet FDA quality standards |
| Appearance and inactive ingredients | The product’s shape, color and other ingredients | Shape, color and some ingredients such as fillers or dyes can differ |
| Price | The price of the brand product | Usually lower, without a lower approval standard |
In practice, a different color is not the same kind of difference as a different strength. Learn which characteristics must match and which can differ. The FDA generic-drug questions and answers explain these similarities and differences.
“Same active ingredient” is therefore a useful starting point, but not a complete product comparison. Two products can share an ingredient and still differ in strength or how the medicine is released.
Bioequivalence and therapeutic equivalence
These terms answer different questions about a drug product.
Bioequivalence concerns how quickly and how much of the active ingredient becomes available to act in the body. It helps establish that a generic delivers the medicine comparably to its reference product. It does not mean that every patient will have an identical experience. FDA explains bioequivalence.
Pharmaceutical equivalence concerns the products themselves: the same active ingredient, strength, dosage form and route. Therapeutic equivalence adds the expectation that matching products will have the same clinical effect and safety profile when used according to their labeling. FDA publishes therapeutic-equivalence evaluations in the Orange Book. FDA’s Orange Book definitions explain the relationship.
Release form is an easy place to miss an important detail. An immediate-release medicine releases the drug promptly; an extended-release medicine releases it over a longer period. Those versions are not automatically interchangeable, even if the ingredient and strength look familiar.
Likewise, two different drugs used for the same condition are not brand/generic versions of each other. Similar treatment purposes do not establish therapeutic equivalence.
What an AB rating means
AB is one type of FDA therapeutic-equivalence code; other codes beginning with A also exist. Where numbered groups such as AB1 and AB2 appear, the full code and matching product group matter. The letters “AB” alone do not establish that products in different groups can replace one another. FDA’s equivalence-code explanations provide the details.
The Orange Book is a scientific reference, not a blanket instruction to substitute every prescription. The pharmacist also considers the prescription and applicable state law. Your study task is to recognize the distinction between identifying a possible equivalent and deciding what may be dispensed.
Why generic medications usually cost less
Generic manufacturers can rely on the reference medicine’s established safety and effectiveness findings instead of repeating the full development program. Their products must still meet FDA approval standards. Competition among manufacturers can also lower prices.
That explains why “less expensive” does not mean “weaker” or “lower quality.” Both brand and generic medicines remain subject to FDA oversight after approval. FDA Generic Drug Facts.
Not every medicine has a generic version. Price tells you what a product costs; equivalence tells you how it compares with a specific reference medicine. One does not establish the other.
Three technician practice scenarios
The following are study situations. Focus on what you notice and what information the pharmacist needs. The PTCB outline’s pharmacist-intervention topics include therapeutic substitution, adverse drug events, allergies and over-the-counter recommendations.
A medication list includes a brand and its ingredient name
A practice medication list includes both Tylenol Regular Strength and acetaminophen. You recognize that they share the same active ingredient. This could be two ways of recording one medicine or a potential duplicate ingredient that needs review.
Flag that overlap for the pharmacist rather than assuming the two names identify different drugs. Recognizing the shared ingredient helps you spot the concern, but the list alone does not establish what the patient is actually taking.
A product description has the wrong release form
A practice prescription specifies an extended-release product, but the product being considered is immediate-release. Matching the generic name is not enough to resolve that difference.
Notice the formulation mismatch and bring it to the pharmacist. Don’t drop release information from your study notes: it can change the meaning of a product description even when the main drug name stays the same.
A patient has a question about a changed refill
A patient says a refill looks different and asks whether the generic is weaker. A manufacturer change can explain a different appearance, but appearance alone does not identify a tablet or resolve a patient concern.
Gather the product details and the patient’s question for the pharmacist. If the patient reports a new symptom, an ingredient allergy or a change in effect, include that information in the handoff. A useful response is, “Let me ask the pharmacist to review this product change with you.” FDA discusses appearance and inactive-ingredient differences.
Related terms you’ll encounter
Authorized generic
An authorized generic is the brand drug product marketed without its brand name. The brand company may sell it itself or permit another company to sell it. It differs from a generic approved through a separate generic application. FDA explains authorized generics.
Biosimilar
A biosimilar is a version of a biologic medicine, a category made from living sources. It must be highly similar to its reference biologic, with no clinically meaningful differences. It is a different category from a conventional generic.
An interchangeable biosimilar has a status that permits pharmacy substitution without consulting the prescriber, subject to state law. That designation does not make it safer or more effective than a biosimilar without the designation. FDA’s biosimilar basics.
Narrow therapeutic index
A narrow therapeutic index means small changes in dose or drug concentration can have serious consequences. FDA examples include warfarin and levothyroxine. The term does not mean a patient always needs a brand product: FDA applies tighter quality and bioequivalence criteria to these generics and considers approved versions clinically substitutable with the brand. FDA’s explanation of narrow-therapeutic-index drugs.
Four study steps for brand and generic medications
Build your recall in both directions. If you can go from Lipitor to atorvastatin but freeze when shown atorvastatin first, practice the reverse direction too.
- Learn a small set of name pairs. Cover the generic column, name the ingredient, then cover the brand column and work backward.
- Connect the ingredient to a drug class. For example, Lipitor → atorvastatin → statin. Add class information from a reliable drug reference rather than guessing from a brand name.
- Keep product details attached. Record the strength, dosage form and release wording when working through a specific product example.
- Explain the distinction aloud. Be able to say why a color change can be acceptable while a strength or release-form mismatch needs attention.
If you want a larger set for recall practice, continue with the Top 200 Drugs study guide. Use the PTCE study guide to fit medication study into your broader preparation plan.
Quick practice
Try these original practice questions before reading the explanations:
- A label says Lipitor (atorvastatin calcium). Which part is the brand name?
- Two products contain the same ingredient and strength, but one is immediate-release and the other is extended-release. Is the name match enough to treat them as interchangeable?
- Which characteristic must an approved generic match: its reference product’s strength or its tablet color?
Answers and explanations
- Lipitor is the brand name. Atorvastatin is the drug ingredient; the label also identifies its calcium salt.
- No. Release form is part of the product comparison. The shared name and strength do not settle equivalence.
- Strength. Tablet color can differ; the matching generic must have the same strength as its reference product.
When reviewing a missed answer, name the detail you overlooked: ingredient, strength, form, route or appearance. That gives your next study session a more useful focus than rereading the same name list.
